lundbeck seattle biopharmaceuticals pharmaceutical development company based bothell washington formerly known alder biopharmaceuticals specializes therapeutic monoclonal antibodies may alder went early company made public stock offering aiming raise company identifies develops manufactures antibody therapeutics alleviate human suffering cancer pain cardiovascular autoimmune inflammatory disease september alder biopharmaceuticals shares increased price following companys acquisition denmarkbased h lundbeck deal valued company subsequently changed name lundbeck seattle biopharmaceuticals article medical pharmaceutical biotechnological corporation company stub help wikipedia expanding ithttpsenwikipediaorgwikilundbeckseattlebiopharmaceuticals